Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.

about

Perioperative and Survival Outcomes Following Neoadjuvant FOLFIRINOX versus Gemcitabine Abraxane in Patients with Pancreatic Adenocarcinoma.

Item

http://www.wikidata.org/entity/Q55380602

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Perioperative and Survival Out ...... ith Pancreatic Adenocarcinoma.

@en

Perioperative and Survival Out ...... ith Pancreatic Adenocarcinoma.

@nl

type

Item

label

Perioperative and Survival Out ...... ith Pancreatic Adenocarcinoma.

@en

Perioperative and Survival Out ...... ith Pancreatic Adenocarcinoma.

@nl

prefLabel

Perioperative and Survival Out ...... ith Pancreatic Adenocarcinoma.

@en

Perioperative and Survival Out ...... ith Pancreatic Adenocarcinoma.

@nl

P1476

Perioperative and Survival Out ...... ith Pancreatic Adenocarcinoma.

@en

P2093

Alessandro Paniccia

http://www.w3.org/2001/XMLSchema#string

Ana Gleisner

http://www.w3.org/2001/XMLSchema#string

Barish H Edil

http://www.w3.org/2001/XMLSchema#string

Brandon C Chapman

http://www.w3.org/2001/XMLSchema#string

Cheryl Meguid

http://www.w3.org/2001/XMLSchema#string

Csaba Gajdos

http://www.w3.org/2001/XMLSchema#string

Devin Rigg

http://www.w3.org/2001/XMLSchema#string

Martin D McCarter

http://www.w3.org/2001/XMLSchema#string

Richard D Schulick

http://www.w3.org/2001/XMLSchema#string

Wells Messersmith

http://www.w3.org/2001/XMLSchema#string

P2860

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

Toxicity and response criteria of the Eastern Cooperative Oncology Group

Diabetes and pancreatic cancer survival: a prospective cohort-based study.

Pathologic response with neoadjuvant chemotherapy and stereotactic body radiotherapy for borderline resectable and locally-advanced pancreatic cancer.

Effects of insulin on human pancreatic cancer progression modeled in vitro

P304

75-85

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29950957

http://www.w3.org/2001/XMLSchema#string

P932

6018015

http://www.w3.org/2001/XMLSchema#string